A Comparison of Inhaled Ipratropium, Oral Theophylline Plus Inhaled β-Agonist, and the Combination of All Three in Patients With COPD
- 1 April 1994
- Vol. 105 (4) , 1089-1094
- https://doi.org/10.1378/chest.105.4.1089
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Bronchodilator Responses to Anticholinergic and Beta-Adrenergic Agents in Acute and Stable COPDChest, 1991
- A Comparison of the Effects of Ipratropium Bromide and Metaproterenol Sulfate in Acute Exacerbations of COPDChest, 1990
- Bronchodilators in Patients with Chronic Obstructive Pulmonary Disease on Mechanical Ventilation: Utilization of Metered-dose InhalersAmerican Review of Respiratory Disease, 1990
- NEBULISED SALBUTAMOL WITH AND WITHOUT IPRATROPIUM BROMIDE IN ACUTE AIRFLOW OBSTRUCTIONThe Lancet, 1989
- Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency roomThe American Journal of Medicine, 1987
- Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: A 90-day multi-center studyThe American Journal of Medicine, 1986
- A Comparison of the Bronchodilating Effects of a Beta-2 Adrenergic Agent (Albuterol) and an Anticholinergic Agent (Ipratropium Bromide), Given by Aerosol Alone or in SequenceNew England Journal of Medicine, 1986
- Anticholinergic and sympathomimetic combination therapy of asthmaJournal of Allergy and Clinical Immunology, 1983
- The Addition of An Aerosol Anticholinergic to An Oral Beta Agonist Plus Theophylline in Asthma and BronchitisChest, 1982
- The Effect of Atropine Inhalation in “Irreversible” Chronic BronchitisChest, 1980